XL 820
Alternative Names: XL-820Latest Information Update: 27 Aug 2010
At a glance
- Originator Exelixis
- Class Antineoplastics; Small molecules
- Mechanism of Action Platelet-derived growth factor inhibitors; Proto-oncogene protein c-kit inhibitors; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastrointestinal stromal tumours; Solid tumours